This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEA610O1_M.jpg
The rising geriatric population, increasing healthcare expenditures, and advances in various drug discoveries have contributed to bullish investor sentiment. This is evident from the iShares Biotechnology ETF’s (IBB) 27.4% return over the past year.
Considering the industry’s promising growth prospects, Wall Street Analysts expect biotechnology stocks Kura Oncology (KURA) and Corvus Pharmaceuticals Inc . (CRVS) to deliver exceptional returns in upcoming months.
